Aerial Biopharma Announces Positive Results For ADX-N05 202; A Phase 2b Trial For Narcolepsy

Tuesday, October 01, 2013

Aerial BioPharma, which has several Chattanooga investors, announced on Tuesday positive results from a Phase 2b clinical study of ADX-N05 in patients with Excessive Daytime Sleepiness associated with narcolepsy.  After completing a successful Phase 2a proof-of concept trial in mid-2012, Aerial began the 12-week, 93 patient, Phase 2b study in September 2012 to validate the results in a larger patient population with a longer duration of treatment.

“The preliminary results are remarkable and have the opportunity to have significant impact on the standard of care for patients with narcolepsy” said Dr. Todd Swick, a clinical investigator in the trial and assistant clinical professor of Neurology, University of Texas School of Medicine-Houston . 

Given the positive results, the company is now planning a strategic asset sale to accelerate the development of N05.  “We are very pleased that we were able to replicate the results from our previous study and are excited about the potential to help patients with this debilitating disease.  As a development-stage company, we have turned our focus to finding a strategic partner that will complete the development and maximize commercialization of this important asset.” said Dr. Moise Khayrallah, CEO and co-founder of Aerial. 

This news comes on the heels of FDA’s Patient-Focused Drug Development Meeting on narcolepsy held on Sept. 24, that highlighted the need for additional research and treatment.  Due to patients’ clamor, narcolepsy was the first rare disease featured in this series of meetings.

Aerial is the third-privately held company from the management team led by Khayrallah, Steve Butts and Gary Bream PhD, all located in the Research Triangle Park, NC area.  Since launching Addrenex Pharmaceuticals in 2006, the team has raised and deployed over $30 million for various drug development programs in central nervous systems conditions.  Addrenex was acquired by Shionogi Pharma in November 2009 and Neuronex, the team's second company, was acquired by Acorda Therapeutics in 2012.  Aerial licensed N05 from SK Biopharmaceuticals.


Blood Assurance Announces August's Giveaway Winner

Blood Assurance, the regional blood center, announced that the winner of its promotional giveaway for August was Adam Ward of Hixson. Adam won a Windows Surface Tablet.   Blood Assurance is a non-profit blood center that serves 47 counties in a 5 state region, and is the provider of blood and blood components for 70 healthcare facilities. Over 440 blood donors are needed ... (click for more)

ClearRiver Health Enters Medicare Advantage Market In Hamilton County

ClearRiver Health, a new, locally based, not-for-profit health plan for Medicare beneficiaries with an emphasis on the physician-patient relationship, access and personal customer service,  will enter the Medicare Advantage market in Hamilton County beginning today.  Founded by Prominence Health, a subsidiary of Catholic Health Initiatives (CHI), ClearRiver Health offers ... (click for more)

Man Found Floating Near Manufacturers Road Was Steven Paul Calhoon, 34

The body found floating in the Tennessee River on Sunday morning downtown has been identified as 34-year-old Steven Paul Calhoon. C hattanooga Police are awaiting the results from the Medical Examiner’s Office to determine the cause of death. At 8:31 a.m.,  the Chattanooga Police Department was dispatched to 530 Manufacturers Road on a found body. Police said ... (click for more)

Bare Majority On County Commission Approves Support For Abortion Amendment

A bare majority of the County Commission on Wednesday morning voted to support an upcoming ballot amendment curbing abortion in Tennessee. Several commissioners said the issue was out of the commission's purview, and the vote should not have taken place. In favor were Sabrena Smedley, Randy Fairbanks, Jim Fields, Marty Haynes and Chester Bankston. Greg Beck and Warren Mackey ... (click for more)

How To Reform The City Industrial Development Board - And Response (3)

My aims is to bring to the public’s attention the need for procedural changes that, if implemented, would significantly improve the information available the public, to the City Council and to the City Industrial Development Board about the verifiable benefits and costs of tax incentive financing structures and to make the entire process transparent. The public, the City ... (click for more)

Roy Exum: My October Garden

Hark! It is the first day of October and, as I make my monthly stroll through the garden, I find a growing numbers of leaves and acorns. Autumn leaves are beautiful while acorns are nuts, thus you will get the idea as we make our monthly awards: A PRETTY LEAF to Phil Hughes after the Minnesota Twins pitcher came within one inning of earning a $500,000 bonus this season. The deal ... (click for more)